Literature DB >> 12000382

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study.

P Coates1, S Vyakrnam, E A Eady, C E Jones, J H Cove, W J Cunliffe.   

Abstract

BACKGROUND: Cutaneous propionibacteria are implicated in acne pathogenesis, although their exact role in the genesis of inflammation is still poorly understood. Agents, including antibiotics, that reduce the numbers of propionibacteria on skin are therapeutic. Resistance in the target organism is a well-recognized consequence of antibiotic therapy for acne but formal prevalence and distribution data are lacking.
OBJECTIVES: To monitor the prevalence of skin colonization by antibiotic-resistant propionibacteria in acne patients attending the dermatology out-patient clinic at Leeds General Infirmary over a 10-year period beginning in 1991, and to examine the distribution of resistant strains on acne-prone skin and in the nares.
METHODS: Propionibacterial samples were obtained from the skin surface of the worst affected site (usually the face) of 4274 acne patients using a moistened swab. The swab was used to inoculate agar plates with and without selective antibiotics. After anaerobic incubation at 37 degrees C for 7 days, the amount of growth in the presence of each antibiotic was scored on a scale from 0 to 5+. A small number of patients (72) were selected for more detailed quantitative sampling at six different sites to examine the distribution of resistant propionibacteria on acne-prone skin and in the anterior nares.
RESULTS: The proportion of patients carrying strains resistant to one or more commonly used antiacne antibiotics rose steadily from 34.5% in 1991 to a peak of 64% in 1997. The prevalence dropped to 50.5% during 1999 and then rose again to 55.5% in 2000. Resistance to erythromycin was the most common and the majority of erythromycin-resistant strains were cross-resistant to clindamycin. Resistance to tetracyclines was less common in all years and with little increase over time. The more detailed quantitative study in 72 patients showed that population densities of resistant propionibacteria varied considerably between sites and between individuals. Almost invariably, patients were colonized with resistant strains at multiple sites, including the nares.
CONCLUSIONS: Skin colonization with antibiotic-resistant propionibacteria is much more common now than a decade ago. Resistant propionibacteria are widely distributed on acne-prone skin and in the nares. This suggests that they will be very difficult to eradicate using existing therapeutic regimens, especially from the nasal reservoir.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000382     DOI: 10.1046/j.1365-2133.2002.04690.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  30 in total

1.  Clinical Efficacy of Self-applied Blue Light Therapy for Mild-to-Moderate Facial Acne.

Authors:  Michael H Gold; Anneke Andriessen; Julie Biron; Hinke Andriessen
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

Review 2.  Acne: more than skin deep.

Authors:  J Ayer; N Burrows
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

3.  Oral antibiotics in acne vulgaris: therapeutic response over 5 years.

Authors:  J Adawiyah; G Priya; B Roshidah
Journal:  Malays Fam Physician       Date:  2010-12-31

4.  Draft genome sequence of an antibiotic-resistant Propionibacterium acnes strain, PRP-38, from the novel type IC cluster.

Authors:  Andrew McDowell; Judit Hunyadkürti; Balázs Horváth; Andrea Vörös; Emma Barnard; Sheila Patrick; István Nagy
Journal:  J Bacteriol       Date:  2012-06       Impact factor: 3.490

5.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use.

Authors:  James Q Del Rosso; Guy F Webster; Ted Rosen; Diane Thiboutot; James J Leyden; Richard Gallo; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

6.  Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes.

Authors:  Jamie E McInturff; Shyh-Jeun Wang; Thomas Machleidt; T Richard Lin; Ami Oren; Cheryl J Hertz; Stephan R Krutzik; Scott Hart; Karin Zeh; Daniel H Anderson; Richard L Gallo; Robert L Modlin; Jenny Kim
Journal:  J Invest Dermatol       Date:  2005-08       Impact factor: 8.551

7.  In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; L Ma; J Sutcliffe; J R Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

8.  In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.

Authors:  James J Leyden; Norman Preston; Cris Osborn; Ronald W Gottschalk
Journal:  J Clin Aesthet Dermatol       Date:  2011-05

Review 9.  Light therapies for acne.

Authors:  Jelena Barbaric; Rachel Abbott; Pawel Posadzki; Mate Car; Laura H Gunn; Alison M Layton; Azeem Majeed; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2016-09-27

10.  Propionibacterium acnes bacteriophages display limited genetic diversity and broad killing activity against bacterial skin isolates.

Authors:  Laura J Marinelli; Sorel Fitz-Gibbon; Clarmyra Hayes; Charles Bowman; Megan Inkeles; Anya Loncaric; Daniel A Russell; Deborah Jacobs-Sera; Shawn Cokus; Matteo Pellegrini; Jenny Kim; Jeff F Miller; Graham F Hatfull; Robert L Modlin
Journal:  MBio       Date:  2012-09-25       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.